Advanced Search

Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2000 May;66(5) > Minerva Anestesiologica 2000 May;66(5):273-7

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036

 

Minerva Anestesiologica 2000 May;66(5):273-7

 UPDATE IN ANAESTHESIA

Why should I change my practice of anaesthesia: neuromuscular blocking agents

Viby-Mogensen J.

From the Department of Anaesthesia and Intensive Care Copenhagen University Hospital, Righospitalet, Copenhagen, Denmark

Background. Recently, ­four neu­ro­mus­cu­lar block­ing ­agents ­have ­been intro­duced ­into clin­i­cal prac­tice. The ­drug com­pa­nies ­claim ­that ­these new ­drugs ­offer sev­er­al impor­tant advan­tag­es. But is ­this ­true? Do the new neu­ro­mus­cu­lar block­ing ­agents add any­thing to our clin­i­cal prac­tice, and ­will ­their intro­duc­tion real­ly ben­e­fit our ­patients? Or ­will it ­only ben­e­fit the econ­o­my of the com­pa­nies?
Purpose of the lec­ture. In ­this lec­ture I ­shall try to ­update you on ­these new ­drugs and ­give you my per­son­al ­bias on ­when to use the dif­fer­ent (new and old) neu­ro­mus­cu­lar block­ing ­agents.

language: English


FULL TEXT  REPRINTS

top of page